Formation of Virus-Like Particles of the Dengue Virus Serotype 2 Expressed in Silkworm Larvae

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Molecular Biotechnology

• Publication date

  2019-08-31

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1007/s12033-019-00210-5PMID 31473916
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recent Developments in Recombinant Protein–Based Dengue Vaccines

  2018cited by this paper
• Enzyme-linked immunosorbent assay using recombinant envelope protein 2 antigen for diagnosis of Chikungunya virus

  2018cited by this paper
• Virus-Like Particle Engineering: From Rational Design to Versatile Applications.

  2018cited by this paper
• Predictable Irreversible Switching Between Acute and Chronic Inflammation

  2018cited by this paper
• Dengue virus-like particles mimic the antigenic properties of the infectious dengue virus envelope

  2018cited by this paper
• A Cost‐Effective Culture System for the In Vitro Assembly, Maturation, and Stimulation of Advanced Multilayered Multiculture Tubular Tissue Models

  2018cited by this paper
• An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design

  2017cited by this paper
• Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age.

  2017cited by this paper
• The first licensed dengue vaccine: an important tool for integrated preventive strategies against dengue virus infection

  2016cited by this paper
• Enveloped virus-like particles as vaccines against pathogenic arboviruses.

  2015cited by this paper
• An optimized expression vector for improving the yield of dengue virus-like particles from transfected insect cells.

  2014cited by this paper
• The True Cost of Greenhouse Gas Emissions: Analysis of 1,000 Global Companies

  2013cited by this paper
• Pichia pastoris-Expressed Dengue 2 Envelope Forms Virus-Like Particles without Pre-Membrane Protein and Induces High Titer Neutralizing Antibodies

  2013cited by this paper
• Recombinant nucleocapsid-like particles from dengue-2 induce functional serotype-specific cell-mediated immunity in mice.

  2012cited by this paper
• Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice

  2011cited by this paper
• Expression of dengue-3 premembrane and envelope polyprotein in lettuce chloroplasts

  2011cited by this paper
• Arbovirus vaccines; opportunities for the baculovirus-insect cell expression system.

  2011cited by this paper
• Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys.

  2010cited by this paper
• Improved expression of fusion protein using a cysteine‐ protease‐ and chitinase‐deficient Bombyx mori (silkworm) multiple nucleopolyhedrovirus bacmid in silkworm larvae

  2008cited by this paper
• Secretion of noninfectious dengue virus-like particles and identification of amino acids in the stem region involved in intracellular retention of envelope protein.

  2005cited by this paper
• Folding and Dimerization of Tick-Borne Encephalitis Virus Envelope Proteins prM and E in the Endoplasmic Reticulum

  2002cited by this paper
• Signal Peptidase Cleavage at the Flavivirus C-prM Junction: Dependence on the Viral NS2B-3 Protease for Efficient Processing Requires Determinants in C, the Signal Peptide, and prM

  1998cited by this paper
• Expression of the dengue virus structural proteins in Pichia pastoris leads to the generation of virus-like particles.

  1997cited by this paper

• A systematic approach for scalable purification of virus-like particles.

  2025cites this paper
• Production of Envelope Protein-Based Virus-like Particles of DENV‑2 in E. coli and Investigation of Their Binding Interactions with Gallic Acid Derivatives of Glucose as Potential Drug Candidates

  2025cites this paper
• From Silkroad to Bioroad-Silkworm Biotechnology.

  2025cites this paper
• Tetravalent Virus-like Particles Engineered To Display Envelope Domain IIIs of Four Dengue Serotypes in Silkworm as Vaccine Candidates.

  2025cites this paper
• Humoral immune response induced with dengue virus-like particles serotypes 1 and 4 produced in silkworm

  2022cites this paper
• The Magic Staff: A Comprehensive Overview of Baculovirus-Based Technologies Applied to Human and Animal Health

  2022cites this paper
• Design and Analysis of a Single System of Impedimetric Biosensors for the Detection of Mosquito-Borne Viruses

  2021cites this paper
• Solutions against emerging infectious and noninfectious human diseases through the application of baculovirus technologies

  2021cites this paper
• Humoral Immune Response in a Mouse Model Induced With Dengue Virus-like Particles Serotypes 1 and 4 Produced in Silkworm Larvae

  2021cites this paper
• Chrysalises as natural production units for recombinant subunit vaccines.

  2020cites this paper
• Production of dengue virus-like particles serotype-3 in silkworm larvae and their ability to elicit a humoral immune response in mice

  2020cites this paper
• Dengue virus-like particles serotype-3 production in silkworm larvae and its capability eliciting a humoral immune response in mice model

  2020cites this paper